Cancer Cell International (Jul 2024)
Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway
- Guang-Zhen Li,
- Guang-Xiao Meng,
- Guo-Qiang Pan,
- Xiao Zhang,
- Lun-Jie Yan,
- Rui-Zhe Li,
- Zi-Niu Ding,
- Si-Yu Tan,
- Dong-Xu Wang,
- Bao-wen Tian,
- Yu-Chuan Yan,
- Zhao-Ru Dong,
- Jian-Guo Hong,
- Tao Li
Affiliations
- Guang-Zhen Li
- Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University
- Guang-Xiao Meng
- Department of General Surgery, Qilu Hospital of Shandong University
- Guo-Qiang Pan
- Department of General Surgery, Qilu Hospital of Shandong University
- Xiao Zhang
- Department of General Surgery, Qilu Hospital of Shandong University
- Lun-Jie Yan
- Department of General Surgery, Qilu Hospital of Shandong University
- Rui-Zhe Li
- Department of General Surgery, Qilu Hospital of Shandong University
- Zi-Niu Ding
- Department of General Surgery, Qilu Hospital of Shandong University
- Si-Yu Tan
- Department of General Surgery, Qilu Hospital of Shandong University
- Dong-Xu Wang
- Department of General Surgery, Qilu Hospital of Shandong University
- Bao-wen Tian
- Department of General Surgery, Qilu Hospital of Shandong University
- Yu-Chuan Yan
- Department of General Surgery, Qilu Hospital of Shandong University
- Zhao-Ru Dong
- Department of General Surgery, Qilu Hospital of Shandong University
- Jian-Guo Hong
- Department of General Surgery, Qilu Hospital of Shandong University
- Tao Li
- Department of General Surgery, Qilu Hospital of Shandong University
- DOI
- https://doi.org/10.1186/s12935-024-03399-x
- Journal volume & issue
-
Vol. 24,
no. 1
pp. 1 – 3
Abstract
No abstracts available.
